Enterprise Value
102.1M
Cash
19.46M
Avg Qtr Burn
-3.884M
Short % of Float
13.93%
Insider Ownership
54.13%
Institutional Own.
13.70%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NXP800 Details Ovarian cancer, Cancer | Phase 1b Data readout | |
NXP800 Details Cancer, Cholangiocarcinoma | Phase 1 Data readout | |
NXP900 Details Cancer, Squamous cancers, Solid tumor/s | Phase 1a Data readout |